A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters
Statistics in Medicine · 2026
DOI: 10.1002/sim.70408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Haidy A Newer. Beteiligte Einrichtung: Department of Mathematics, Faculty of Education, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Multicenter Studies as Topic, Models, Statistical, Clinical Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Statistical inference in multicenter clinical trials is often compromised when relying on asymptotic normal approximations, particularly in designs characterized by a small number of centers or severe imbalance in patient enrollment. Such deviations from asymptotic assumptions frequently result in unreliable p ‐values and a breakdown of error control. To resolve this, we introduce a high‐precision saddlepoint approximation framework for aggregate permutation tests within hierarchically structured data. The theoretical core of our approach is the derivation of a multilevel nested cumulant generating function that explicitly models the trial hierarchy, analytically integrating patient‐level linear rank statistics with the stochastic aggregation process across centers. A significant innovation of this work is the extension to the bivariate setting to address co‐primary endpoints , providing a robust inferential solution for mixed continuous (efficacy) and discrete (safety) outcomes where standard multivariate normality is unattainable. The resulting framework yields simulation‐free, highly accurate tail probabilities even in finite‐sample regimes. Extensive simulation studies confirm that our method maintains strict Type I error control in scenarios where asymptotic methods exhibit substantial inflation. Furthermore, an application to the multicenter diabetes prevention program trial demonstrates the method's practical utility: it correctly identifies a significant cardiovascular risk factor that standard approximations failed to detect, thereby preventing a critical Type II error and ensuring valid clinical conclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mathematics, Faculty of Education, Ain Shams University, Cairo, Egypt.
ORCID-Profile: Haidy A Newer
Zitieren
APA
Newer, H. A. (2026). A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters. Statistics in Medicine. https://doi.org/10.1002/sim.70408
Vancouver
Newer HA. A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters. Statistics in Medicine. 2026. doi:10.1002/sim.70408
BibTeX
@article{Newer2026,
author = {Newer, Haidy A},
title = {A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters},
journal = {Statistics in Medicine},
year = {2026},
doi = {10.1002/sim.70408}
}
EUVIMED